This inventor holds 12 USPTO granted patents. Top assignee: The Liposome Company, Inc.. Active years: 1996-2006.
Location History:
- Alaknanda, IN (1996)
- Plainsboro, NJ (US) (1997)
- New Delhi, IN (1998 - 2006)
Company Filing History:
Years Active: 1996-2006
Title: Suresh K Bhatia: Innovator in Liposome Technology
Introduction
Suresh K Bhatia is a prominent inventor based in New Delhi, India. He has made significant contributions to the field of liposome technology, particularly in therapeutic applications. With a total of 12 patents to his name, Bhatia's work has the potential to impact various medical treatments.
Latest Patents
Among his latest patents is the invention of etherlipid-containing multiple lipid liposomes. These liposomes incorporate etherlipids along with phosphatidylcholine, sterols, and headgroup-derivatized lipids. They are designed for use in therapeutic regimens, particularly for treating cancers and inflammatory disorders. Another notable patent involves hydrophobic taxane derivatives, which provide innovative solutions in cancer treatment.
Career Highlights
Bhatia is associated with The Liposome Company, Inc., where he continues to advance research in liposome technology. His work has garnered attention for its potential applications in various therapeutic areas.
Collaborations
Throughout his career, Bhatia has collaborated with notable professionals in the field, including Andrew S Janoff and Eric G Mayhew. These collaborations have further enriched his research and development efforts.
Conclusion
Suresh K Bhatia's contributions to liposome technology exemplify the innovative spirit of modern inventors. His patents reflect a commitment to advancing medical treatments and improving patient outcomes.